• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Adial Pharmaceuticals, Inc - Common Stock (NQ:ADIL)

    0.6850 -0.0350 (-4.86%)
    Streaming Delayed Price Updated: 3:57 PM EDT, Apr 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20,463
    Open 0.7000
    Bid (Size) 0.6850 (8)
    Ask (Size) 0.7300 (30)
    Prev. Close 0.7200
    Today's Range 0.6824 - 0.7200
    52wk Range 0.5759 - 3.000
    Shares Outstanding 20,298,156
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder
    Adial Pharmaceuticals secured FDA support for its AD04 bridging strategy, paving the way for Phase 3 trials in 2025 after confirming bioequivalence. 
    Via Benzinga
    Exposures Product Safety

    Performance

    YTD
    -35.4%
    -35.4%
    1 Month
    -2.2%
    -2.2%
    3 Month
    -30.0%
    -30.0%
    6 Month
    -37.7%
    -37.7%
    1 Year
    -60.4%
    -60.4%

    More News

    Read More
    EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    EXCLUSIVE: Adial Pharmaceuticals Reveals Positive Pharmacokinetics Study Results Of AD04 For Alcohol Use Disorder
    Via Benzinga
    EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
    Via Benzinga
    Exposures Product Safety
    This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
    Via Benzinga
    EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    ADIL Stock Earnings: Adial Pharmaceuticals Reported Results for Q2 2024
    Via InvestorPlace
    EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder
    Via Benzinga
    EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4
    Via Benzinga
    Gold Moves Higher; Coca-Cola Increases FY24 Forecast
    Via Benzinga
    Why Is Serve Robotics (SERV) Stock Down Today?
    Via InvestorPlace
    Why Is Jaguar Health (JAGX) Stock Down 55% Today?
    Via InvestorPlace
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 2%; GE Aerospace Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?
    Via InvestorPlace
    US Stocks Edge Higher; General Motors Posts Upbeat Earnings
    Via Benzinga
    EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder
    Via Benzinga
    ADIL Stock Earnings: Adial Pharmaceuticals Beats EPS for Q4 2023
    Via InvestorPlace
    EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
    Via Benzinga
    MicroCap Rodeo’s Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies
    Via ACCESSWIRE
    Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
    Via InvestorPlace
    EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
    Via Benzinga

    Frequently Asked Questions

    Is Adial Pharmaceuticals, Inc - Common Stock publicly traded?
    Yes, Adial Pharmaceuticals, Inc - Common Stock is publicly traded.
    What exchange does Adial Pharmaceuticals, Inc - Common Stock trade on?
    Adial Pharmaceuticals, Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Adial Pharmaceuticals, Inc - Common Stock?
    The ticker symbol for Adial Pharmaceuticals, Inc - Common Stock is ADIL on the Nasdaq Stock Market
    What is the current price of Adial Pharmaceuticals, Inc - Common Stock?
    The current price of Adial Pharmaceuticals, Inc - Common Stock is 0.6850
    When was Adial Pharmaceuticals, Inc - Common Stock last traded?
    The last trade of Adial Pharmaceuticals, Inc - Common Stock was at 04/25/25 03:57 PM ET
    What is the market capitalization of Adial Pharmaceuticals, Inc - Common Stock?
    The market capitalization of Adial Pharmaceuticals, Inc - Common Stock is 13.90M
    How many shares of Adial Pharmaceuticals, Inc - Common Stock are outstanding?
    Adial Pharmaceuticals, Inc - Common Stock has 14M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.